BRAF and thyroid cancer: Interestingly, vascular invasion disappeared in tumors with WIPF1 knockdown as in tumors with BRAF V600E knockdown, providing functionally in vivo evidence for a role of WIPF1 in the invasiveness of thyroid cancer.